Special Relevant Publications

(This page last modified 6/10/99)
1. KHW Lau and DJ Baylink: Molecular Mechanism of Action of Fluoride on Bone Cells. J Bone Miner Res 13:1660-1667, 1998
1a. M Susa: Heterotrimeric G Proteins as Fluoride Targets in Bone (Review). Int J Mol Med 3:115-26, 1999.
2. SM Farley et al: Spinal Fractures During Fluoride Therapy for Osteoporosis. Relationship to Spinal Bone Density. Osteoporosis Intl 2:213-218, 1992.
3. CS Vattikonda, WA Ritschel, CHerbert: Biopharmaceutic Approach in Designing a Controlled Release Tablet of Sodium Monofluorophosphate: Characterization of Absorption Sites and Evaluation of Modified Dosage Form. Intl J Clin Pharmacol Therap 32:559-566, 1994. (In 1996, Ritschel received a major NIH-award to establish a Pharmaceutical Sciences Research Center at U. Cincinnati).
4. F Liote et al: Bioavailability of Fluoride in Posmenopausal Women: Comparative Study Between Sodium Fluoride and Disodium Monofluorophosphate-Calcium Carbonate. Calcif Tissue 50: 209-213, 1992.
5. I Setnikar and H Maurer: Bioequivalence of Sodium Monofluorophosphate with Sodium Fluoride and Compatibility with Calcium. Arneim-Forsch/Drug Research 40:994-999, 1990. 
5a. I Setnikar et al: Bioavailability and Pharmacokinetic Characteristics of Two Monofluorophosphate Preparations with Calcium Supplement. Arznei-Forsch 48:1172-8, 1998.
6. S Patel et al: Fluoride Pharmacokinetics and Changes in Lumbar Spine and Hip Bone Mineral Density. Bone 19:651-655, 1996

For Additional literature references contact:

Osteoporosis and Related Bone Diseases-National Resource Center
(sponsored by NIH and National Bone Disease Foundations)
1150 17th Street, NW, Suite 500
Washington, DC 20036-4603
800-624-2663 / Fax 202-223-2237